Shareholders Approve the Election of All Three Athira
BOTHELL, Wash., May 19, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on...
Source: globenewswire.com
Page 4 - Mark Litton News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mark Litton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mark Litton Today - Breaking & Trending Today
Athira Pharma Reports First Quarter 2022 Financial Results and Provides Pipeline and Business Updates
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Ric Kayne Files Definitive Proxy Materials for Athira's 2022 Annual Meeting
Sends Letter to Athira’s Shareholders Seeking Replacement of CEO Dr. Mark LittonHighlights New Management and Shareholder Centric Directors Are Required to Provide Proper Oversight of ATH-1017 Clinical Trials to Maximize Likelihood of SuccessUrges ATHA Shareholders to VOTE the BLUE Proxy Card NEW YORK--(BUSINESS WIR...
Source: pharmiweb.com
Leen Kawas Business Partner Stirs Up More Drama at Athira
Athira Pharma is circling the wagons and urging shareholders to reject investor Richard Kayne's calls for a management change.
Source: biospace.com
Billionaire investor launches board fight at Athira, wants CEO replaced
By Svea Herbst-Bayliss BOSTON (Reuters) - Billionaire investor Richard (Ric) Kayne is seeking two board seats at Athira Pharma, arguing the biotech co...
Source: whbl.com